Indium In 111 Pentetreotide vs Pembrolizumab
Indium In 111 Pentetreotide vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Indium In 111 Pentetreotide and Pembrolizumab.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days.
Chemical Properties
Type: Indium In 111 Pentetreotide — Protein; Pembrolizumab — Antibody.